Who owns ELIEM THERAPEUTICS INC?
- Ticker: CLYM
- CUSIP Number: 28658r106
Tip: Access positions for across all investors
Analyze quarterly positions in Eliem Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Eliem Therapeutics stock
Who bought or sold ELIEM THERAPEUTICS INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| RA Capital Management | 31M | $160M | 0% | Sep 2024 |
|
| Samsara BioCapital | 2.6M | $13M | -20% | Sep 2024 |
|
| Boxer Capital | 2.6M | $13M | 0% | Sep 2024 |
|
| BlackRock | 1.9M | $9.5M | 100% | Sep 2024 |
|
| Affinity Asset Advisors | 1.5M | $7.6M | -10% | Sep 2024 |
|
| T. Rowe Price Associates | 673k | $3.4M | 100% | Sep 2024 |
|
| Geode Capital Management | 651k | $3.3M | 280% | Sep 2024 |
|
| Driehaus Capital Management | 612k | $3.1M | -12% | Sep 2024 |
|
| Point72 Asset Management | 591k | $3.0M | 100% | Sep 2024 |
|
| Nan Fung Group Holdings | 464k | $2.4M | 100% | Sep 2024 |
|
| Northern Trust | 293k | $1.5M | 100% | Sep 2024 |
|
| Dr. Jeffrey R. Jay, M.D. | 248k | $1.3M | 100% | Sep 2024 |
|
| Monashee Investment Management | 230k | $1.2M | 100% | Sep 2024 |
|
| Ikarian Capital | 175k | $891k | 75% | Sep 2024 |
|
| TD Asset Management | 89k | $445k | 100% | Sep 2024 |
|
| Charles Schwab Investment Management | 70k | $357k | 309% | Sep 2024 |
|
| Renaissance Technologies | 69k | $349k | 85% | Sep 2024 |
|
| Bank of New York Mellon | 65k | $330k | 244% | Sep 2024 |
|
| Segall Bryant & Hamill | 58k | $297k | 100% | Sep 2024 |
|
| Barclays | 39k | $198k | 1428% | Sep 2024 |
|
| Rhumbline Advisers | 28k | $141k | 237% | Sep 2024 |
|
| Winton Capital | 28k | $140k | 100% | Sep 2024 |
|
| Citigroup | 21k | $109k | 1212% | Sep 2024 |
|
| Dimensional Fund Advisors | 18k | $93k | 46% | Sep 2024 |
|
| MetLife Investment Advisors | 18k | $90k | 100% | Sep 2024 |
|
| Bank of America Corporation | 17k | $88k | 88% | Sep 2024 |
|
| Chicago Partners Investment | 17k | $81k | 100% | Sep 2024 |
|
| Mirae Asset Global Etfs Holdings | 16k | $82k | 100% | Sep 2024 |
|
| American Century Companies | 14k | $71k | 100% | Sep 2024 |
|
| Wells Fargo & Company | 13k | $67k | 321% | Sep 2024 |
|
| Jpmorgan Chase & Co | 13k | $65k | 312% | Sep 2024 |
|
| Valence8 US | 12k | $61k | 100% | Sep 2024 |
|
| SG Americas Securities | 12k | $60k | 100% | Sep 2024 |
|
| Jane Street | 11k | $56k | 100% | Sep 2024 |
|
| New York State Common Retirement Fund | 11k | $53k | -21% | Sep 2024 |
|
| AQR Capital Management | 10k | $53k | 100% | Sep 2024 |
|
| Advisor Group Holdings | 8.3k | $22k | 100% | Sep 2024 |
|
| OTR - Nominee Name for The State Teachers Retirement Board of Ohio | 5.3k | $27k | 0% | Sep 2024 |
|
| Royal Bank of Canada | 3.5k | $17k | 406% | Sep 2024 |
|
| Summit Investment Advisors | 3.0k | $15k | 318% | Sep 2024 |
|
| California State Teachers Retirement System | 2.2k | $11k | 311% | Sep 2024 |
|
| Quadrant Capital | 488.00 | $2.5k | 100% | Sep 2024 |
|
| Signature | 333.00 | $1.7k | 100% | Sep 2024 |
|
| Amalgamated Bank | 252.00 | $1.0k | 0% | Sep 2024 |
|
| Us Bancorp | 141.00 | $718.000200 | 100% | Sep 2024 |
|
| Sterling Capital Management | 112.00 | $570.001600 | 100% | Sep 2024 |
|
| CWM | 20.00 | $0 | 100% | Sep 2024 |
|
Who sold out of Eliem Therapeutics?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Man Group | Jun 2024 | 34k | $239k |
| Woodline Partners | Jun 2024 | 22k | $158k |
| Millennium Management | Jun 2024 | 11k | $81k |
| Polar Securities | Jun 2024 | 11k | $77k |